Endevica Bio
No bio yet
This person is not in any teams
This person is not in any offices
Endevica Bio
Endevica Bio's lead drug candidate is a peptide therapeutic for treating cachexia due to cancer and other chronic conditions. Phase 1 Clinical trials in the US are underway.